JP2004520296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004520296A5 JP2004520296A5 JP2002549329A JP2002549329A JP2004520296A5 JP 2004520296 A5 JP2004520296 A5 JP 2004520296A5 JP 2002549329 A JP2002549329 A JP 2002549329A JP 2002549329 A JP2002549329 A JP 2002549329A JP 2004520296 A5 JP2004520296 A5 JP 2004520296A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkanoyl
- alkanoylamino
- amino
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 125000001589 carboacyl group Chemical group 0.000 claims description 18
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 239000001257 hydrogen Substances 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 10
- -1 amino, hydroxy, aminomethyl Chemical group 0.000 claims description 8
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000004647 alkyl sulfenyl group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000001475 halogen functional group Chemical group 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 4
- 125000006413 ring segment Chemical group 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims description 2
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims description 2
- 125000000539 amino acid group Chemical group 0.000 claims description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 125000002837 carbocyclic group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000002950 monocyclic group Chemical group 0.000 claims description 2
- 125000003367 polycyclic group Chemical group 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 2
- 125000004750 (C1-C6) alkylaminosulfonyl group Chemical group 0.000 claims 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 1
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2000/004764 WO2001044226A1 (en) | 1999-12-14 | 2000-12-13 | Serine protease inhibitors |
| GBGB0114185.2A GB0114185D0 (en) | 2001-06-12 | 2001-06-12 | Compounds |
| PCT/GB2001/005526 WO2002047762A1 (en) | 2000-12-13 | 2001-12-12 | Serine protease inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004520296A JP2004520296A (ja) | 2004-07-08 |
| JP2004520296A5 true JP2004520296A5 (cg-RX-API-DMAC7.html) | 2010-02-12 |
| JP4452017B2 JP4452017B2 (ja) | 2010-04-21 |
Family
ID=9916341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002549329A Expired - Fee Related JP4452017B2 (ja) | 2000-12-13 | 2001-12-12 | セリンプロテアーゼインヒビター |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7067516B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1343561B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4452017B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100814227B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE355101T1 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2220702A (cg-RX-API-DMAC7.html) |
| BR (1) | BR0116166A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2436935C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60126978T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2282192T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0114185D0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03005254A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002047762A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| ES2275683T3 (es) * | 2000-06-13 | 2007-06-16 | Tularik Limited | Inhibidores de la serino proteasa. |
| US7074934B2 (en) * | 2000-06-13 | 2006-07-11 | Tularik Limited | Serine protease inhibitors |
| US7138529B2 (en) * | 2003-04-16 | 2006-11-21 | Hoffmann-La Roche Inc. | Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| DE102004006808A1 (de) * | 2004-02-11 | 2005-09-01 | Grünenthal GmbH | Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen |
| EP1753512B1 (en) | 2004-05-28 | 2008-07-09 | Nycomed GmbH | Tetrahydropyridothiophenes |
| JP2008501768A (ja) | 2004-06-11 | 2008-01-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規の化合物及びテトラヒドロピリドチオフェンの使用 |
| CA2576971A1 (en) * | 2004-08-20 | 2006-03-02 | Entremed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
| CA2596202A1 (en) | 2005-02-09 | 2006-08-17 | Altana Pharma Ag | Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer |
| JP2008530053A (ja) | 2005-02-11 | 2008-08-07 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌の治療のための抗増殖性剤としてのテトラヒドロピリドチオフェン |
| AU2006251169A1 (en) | 2005-05-25 | 2006-11-30 | 4Sc Ag | Tetrahydropyridothiophenes for use in the treatment of cancer |
| AU2006251167A1 (en) | 2005-05-25 | 2006-11-30 | 4Sc Ag | Tetrahydropyridothiophenes for use in the treatment of cancer |
| AU2007207743B2 (en) * | 2006-01-18 | 2010-07-08 | Amgen Inc. | Thiazole compounds as protein kinase B (PKB) inhibitors |
| US7919504B2 (en) * | 2007-07-17 | 2011-04-05 | Amgen Inc. | Thiadiazole modulators of PKB |
| US7897619B2 (en) | 2007-07-17 | 2011-03-01 | Amgen Inc. | Heterocyclic modulators of PKB |
| AR075899A1 (es) * | 2009-03-20 | 2011-05-04 | Onyx Therapeutics Inc | Tripeptidos epoxicetonas cristalinos inhibidores de proteasa |
| MY162557A (en) | 2010-02-26 | 2017-06-15 | Oral Health Australia Pty Ltd | Treatment or prevention of infection |
| CN103435573B (zh) * | 2013-07-16 | 2015-04-01 | 浙江医药高等专科学校 | 苄基取代的噻唑并环己烷类化合物、其制备方法和用途 |
| CN103408541B (zh) * | 2013-07-16 | 2015-04-01 | 浙江医药高等专科学校 | 吲哚取代的噻唑并环己烷类化合物、及其抗肿瘤用途 |
| AU2014304562B8 (en) | 2013-08-08 | 2018-07-05 | Galapagos Nv | Thieno[2,3-c]pyrans as CFTR modulators |
| PE20210097A1 (es) | 2018-06-19 | 2021-01-12 | Novartis Ag | Derivados de tetrahidrotienopiridina n-sustituidos y sus usos |
| CN112566910B (zh) * | 2018-06-21 | 2025-09-09 | Ucb生物制药有限责任公司 | 用于治疗由IgE引起的疾病的噻吩衍生物 |
| SG11202105190SA (en) * | 2018-11-19 | 2021-06-29 | 11949098 Canada Inc | 4,5,6,7-tetrahydro-l-benzothiophene modulators of retinoic acid receptor related (rar) orphan nuclear receptors (rors) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL123986A (en) | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
| WO1999011658A1 (en) * | 1997-08-29 | 1999-03-11 | Proteus Molecular Design Ltd. | Meta-benzamidine derivatives as serin protease inhibitors |
| WO1999055661A1 (en) | 1998-04-24 | 1999-11-04 | Proteus Molecular Design Limited | Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| CA2375920A1 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Compounds |
| CA2383008A1 (en) * | 1999-06-14 | 2000-12-21 | Amanda Jane Lyons | Compounds |
| GB9929552D0 (en) * | 1999-12-14 | 2000-02-09 | Proteus Molecular Design | Compounds |
| AU2001264077B2 (en) * | 2000-06-13 | 2006-08-10 | Tularik Limited | Serine protease inhibitors |
-
2001
- 2001-06-12 GB GBGB0114185.2A patent/GB0114185D0/en not_active Ceased
- 2001-12-12 JP JP2002549329A patent/JP4452017B2/ja not_active Expired - Fee Related
- 2001-12-12 MX MXPA03005254A patent/MXPA03005254A/es active IP Right Grant
- 2001-12-12 WO PCT/GB2001/005526 patent/WO2002047762A1/en not_active Ceased
- 2001-12-12 EP EP01270360A patent/EP1343561B1/en not_active Expired - Lifetime
- 2001-12-12 AT AT01270360T patent/ATE355101T1/de not_active IP Right Cessation
- 2001-12-12 CA CA2436935A patent/CA2436935C/en not_active Expired - Fee Related
- 2001-12-12 KR KR1020037007835A patent/KR100814227B1/ko not_active Expired - Fee Related
- 2001-12-12 ES ES01270360T patent/ES2282192T3/es not_active Expired - Lifetime
- 2001-12-12 DE DE60126978T patent/DE60126978T2/de not_active Expired - Lifetime
- 2001-12-12 BR BR0116166-0A patent/BR0116166A/pt not_active Application Discontinuation
- 2001-12-12 AU AU2220702A patent/AU2220702A/xx active Pending
- 2001-12-12 AU AU2002222207A patent/AU2002222207B2/en not_active Ceased
- 2001-12-12 US US10/432,365 patent/US7067516B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2862375B2 (ja) | Crfアンタゴニストとしてのピラゾロピリミジン | |
| JP2002520316A5 (cg-RX-API-DMAC7.html) | ||
| CA2272291A1 (en) | Crf antagonistic quino- and quinazolines | |
| HRP20090250T1 (hr) | Kondenzirani heterociklički spojevi i njihova upotreba kao inhibitora hcv polimeraze | |
| EP1400518A4 (en) | DERIVATIVES OF HETEROCYCLIC COMPOUNDS AND MEDICINAL PRODUCTS | |
| ATE315022T1 (de) | Prostaglandinanaloga als ep4-rezeptoragonisten | |
| PL377112A1 (pl) | Sposoby wytwarzania związków pirolotriazynowych użytecznych jako inhibitory kinazy | |
| JP2004516293A5 (cg-RX-API-DMAC7.html) | ||
| DK1720881T3 (da) | 11-hydroxy-5h-(2,1-c)(1,4)benzodiazepin-5-on-derivater som nøglemellemprodukter i fremstilling afc2-substituerede pyrrolobenzodiazepiner | |
| KR950018010A (ko) | 단백질 키나제 c억제제 | |
| EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
| AR037465A1 (es) | Compuesto derivado de 5-sulfanil-4h-1,2,4-triazol, composicion farmaceutica que lo comprende y proceso para su preparacion en fase liquida | |
| MEP12608A (en) | Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | |
| DE602004031722D1 (de) | Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden | |
| WO2004013100A3 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| CA2421504A1 (en) | 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors | |
| AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
| JP2004504323A5 (cg-RX-API-DMAC7.html) | ||
| JP2002519408A5 (cg-RX-API-DMAC7.html) | ||
| PE20020524A1 (es) | 7-oxo-piridopirimidinas como inhibidores de quinasas | |
| WO2003075907A3 (en) | Small molecule entry inhibitors | |
| ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
| HRP20030610B1 (en) | Process for the preparation of mesylates of piperazine derivatives | |
| YU64901A (sh) | Derivati bifenila | |
| DE60013260D1 (de) | Anivirale 2,4-pyrimidindion-derivate und ein verfahren zu ihrer herstellung |